Dentsply Sirona Inc. (XRAY)
XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative
XRAY climbs nearly 8% pre-market as it unveils a $120M restructuring plan, even after Q4 earnings miss and softer 2026 outlook.
DENTSPLY SIRONA Inc. (XRAY) Q4 2025 Earnings Call Transcript
DENTSPLY SIRONA Inc. (XRAY) Q4 2025 Earnings Call Transcript
Dentsply (XRAY) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Dentsply International (XRAY) Q4 Earnings Miss Estimates
Dentsply International (XRAY) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.26 per share a year ago.
DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock?
XRAY gears up for Q4 results amid U.S. weakness, tariff headwinds and a lowered outlook as investors watch for signs of stabilization.
Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DENTSPLY SIRONA Inc. (XRAY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
DENTSPLY SIRONA Inc. (XRAY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Unlocking Dentsply (XRAY) International Revenues: Trends, Surprises, and Prospects
Explore how Dentsply's (XRAY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View
DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.
DENTSPLY SIRONA Inc. (XRAY) Q3 2025 Earnings Call Transcript
DENTSPLY SIRONA Inc. ( XRAY ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Wade Moody Daniel Scavilla - President, CEO & Director Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division David Saxon - Needham & Company, LLC, Research Division Jordan Bernstein - Stifel, Nicolaus & Company, Incorporated, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Erin Wilson Wright - Morgan Stanley, Research Division Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Ahmed Muhammad Rahat - Leerink Partners LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Allen Lutz - BofA Securities, Research Division Brandon Vazquez - William Blair & Company L.L.C.
Compared to Estimates, Dentsply (XRAY) Q3 Earnings: A Look at Key Metrics
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock?
Dentsply Sirona's Q3 results may reveal ongoing softness in U.S. demand and orthodontic segments despite steady cost control.
